HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome.
Golkaram M, Salmans ML, Kaplan S, Vijayaraghavan R, Martins M, Khan N, Garbutt C, Wise A, Yao J, Casimiro S, Abreu C, Macedo D, Costa AL, Alvim C, Mansinho A, Filipe P, Marques da Costa P, Fernandes A, Borralho P, Ferreira C, Aldeia F, Malaquias J, Godsey J, So A, Pawlowski T, Costa L, Zhang S, Liu L.
Golkaram M, et al. Among authors: costa al, costa l.
NPJ Genom Med. 2021 Feb 15;6(1):13. doi: 10.1038/s41525-021-00177-w.
NPJ Genom Med. 2021.
PMID: 33589643
Free PMC article.